Chronic Kidney Disease Clinical Trials in Madrid
7 recruitingMadrid, Spain
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
Phase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Novo Nordisk A/S465 enrolled147 locationsNCT06717698
Recruiting
Phase 3
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Chronic Kidney DiseaseRenal Anemia
Astellas Pharma Global Development, Inc.100 enrolled47 locationsNCT05970172
Recruiting
OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD
Chronic Kidney Disease
AstraZeneca14,308 enrolled1 locationNCT07450820
Recruiting
Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuria
Bayer219 enrolled154 locationsNCT05196035
Recruiting
Not Applicable
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
DepressionChronic Kidney Diseases
Universidad Europea de Madrid104 enrolled1 locationNCT06109493
Recruiting
Phase 3
Keeping RAASi Treatment With Optimal Potassium Control
Chronic Kidney Diseases
Fundación para la Investigación del Hospital Clínico de Valencia78 enrolled5 locationsNCT06578533